J., 300(Pt. 1), 211-216
(1994).
3. Holtzman, D, et al., Brain creatine phosphate and
creatine kinase in mice fed an analogue of
creatine. Brain Res., 483(1), 68-77 (1989).
4. Fitch, C. D., et
with cGMP’s
(21 CFR parts 210 and 211) and related guidance documents
like FDA’s Guidance on Sterile Drug Product Produced by
Aseptic Processing (ref.4), EU cGMP Annex 1 (ref.5) or PDA
solution of the reference gene-specific
probe.
05 046 211 001 2 vials,
100 μl each
2 vials,
100 μl each
http://lifescience.roche.com
4 lifescience.roche.com
1. General Information
solution of the reference gene-specific
probe.
05 046 211 001 2 vials,
100 μl each
2 vials,
100 μl each
http://lifescience.roche.com
4 lifescience.roche.com
1. General Information
solution of the reference gene-specific
probe.
05 046 211 001 2 vials,
100 μl each
2 vials,
100 μl each
http://sigmaaldrich.com
4 sigma-aldrich.com
1. General Information
y
solution of the reference gene-specific
probe.
05 046 211 001 2 vials,
100 μl each
2 vials,
100 μl each
http://sigmaaldrich.com
4 sigma-aldrich.com
1. General Information
y
solution of the reference gene-specific
probe.
05 046 211 001 2 vials,
100 μl each
2 vials,
100 μl each
http://lifescience.roche.com
4 lifescience.roche.com
1. General Information
MYO1C P NP_001074248.1 y y y
482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
483 Myosin Va M5062 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
484 Myosin VI M0691 4646 MYO6 M
MYO1C P NP_001074248.1 y y y
482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
483 Myosin Va M5062 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
484 Myosin VI M0691 4646 MYO6 M
MYO1C P NP_001074248.1 y y y
482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
483 Myosin Va M5062 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
484 Myosin VI M0691 4646 MYO6 M
VCAM-1, and ICAM-1. A 100 mM (10 mg/483
µl) solution of BAY 11-7082 (Cat. No.196871) in DMSO is also available is also available.
10 mg
BAY 11-7085 196872 {(e)3-[(4-t-Butylphenyl)sulfonyl]-2-propenenitrile
analysis at trace levels by means
of a matrix-compatible coating, Talanta. 211 (2020). https://doi.
org/10.1016/j.talanta.2020.120746.
4. Souza-Silva É.A.; Pawliszyn J, Direct immersion solid-phase
microextraction
Cy3+Cy5 C0992 M NA NA NA
481 Myosin Light Chain Kinase M7905 M y y Y
482 Myosin Va M4812 P n/d n/d y
483 Myosin Va M5062 P n/d n/d y
484 Myosin VI M0691 M y y y
485 Myosin VI M5187 P
482 Myosin Va M4812 25017, 17918, 4644 Myo5a,MYO5A NP_071514.1,NP_034994.2,NP_000250.2 P n/d n/d y
483 Myosin Va M5062 25017, 17918, 4644 Myo5a,MYO5A NP_071514.1,NP_034994.2,NP_000250.2 P n/d n/d y
484
482 Myosin Va M4812 25017, 17918, 4644 Myo5a,MYO5A NP_071514.1,NP_034994.2,NP_000250.2 P n/d n/d y
483 Myosin Va M5062 25017, 17918, 4644 Myo5a,MYO5A NP_071514.1,NP_034994.2,NP_000250.2 P n/d n/d y
484